ICD-10 Code C25.4 | Malignant neoplasm of endocrine pancreas Symptoms, Diagnosis, Billing

Malignant neoplasm of the endocrine pancreas refers to cancerous tumors originating in the hormone-producing cells of the pancreas. This condition is clinically significant due to its potential for aggressive behavior and poor prognosis. Accurate coding with ICD-10 Code C25.4 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this serious condition.

What is ICD-10 Code C25.4 for Malignant neoplasm of endocrine pancreas?

ICD-10 Code C25.4 represents a malignant neoplasm specifically located in the endocrine pancreas, which includes tumors such as insulinomas and gastrinomas. This code should be used in clinical documentation and billing when a patient is diagnosed with this type of pancreatic cancer, allowing for appropriate treatment planning and resource allocation.

ICD-10 Code C25.4 – Clinical Definition and Explanation of Malignant neoplasm of endocrine pancreas

Malignant neoplasms of the endocrine pancreas arise from the islet cells and can lead to significant metabolic disturbances. These tumors may progress rapidly and require immediate medical intervention due to their potential for metastasis and complications. Early diagnosis and treatment are crucial for improving patient outcomes.

Key Clinical Features:

• Hyperglycemia or hypoglycemia due to hormone secretion.
• Abdominal pain or discomfort.
• Weight loss and anorexia.
• Jaundice in advanced cases.

ICD-10 Code C25.4 for Malignant neoplasm of endocrine pancreas – SOAP Notes & Clinical Use

ICD-10 Code C25.4 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It plays a critical role in both acute and chronic care settings, ensuring comprehensive documentation that supports clinical decision-making and billing processes.

What Does ICD-10 Code C25.4 for Malignant neoplasm of endocrine pancreas Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C25.4 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of malignant neoplasm of the endocrine pancreas. This coding ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code C25.4 – Malignant neoplasm of endocrine pancreas

The management of malignant neoplasm of the endocrine pancreas often requires hospitalization due to the complexity of treatment and potential complications.

Antibiotic Therapy:

Supportive Care:

• Nutritional support to manage weight loss.
• Pain management strategies.
• Monitoring of blood glucose levels.

Infection Control:

How to Document Symptoms of Malignant neoplasm of endocrine pancreas (ICD-10 C25.4) in SOAP Notes

Subjective:

• Patient reports persistent abdominal pain.
• History of unexplained weight loss over the past few months.
• Complaints of fatigue and weakness.
• Episodes of hypoglycemia.

Objective:

• Abdominal tenderness on examination.
• Elevated blood glucose levels.
• Imaging shows a mass in the pancreas.
• Weight loss of 10% since last visit.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Malignant neoplasm of endocrine pancreas (ICD-10 Code C25.4)

Assessment:

• Diagnosis: Malignant neoplasm of endocrine pancreas, C25.4.
• Severity: Advanced stage due to weight loss and metabolic disturbances.
• Contributing factors: Possible genetic predisposition.
• Triggers: Uncontrolled hormone secretion.

Plan:

• Refer to oncology for further evaluation and treatment options.
• Initiate pain management protocol.
• Schedule follow-up imaging to monitor tumor progression.
• Educate patient on dietary modifications.

Treatment & Plan Section for ICD-10 Code C25.4 – Malignant neoplasm of endocrine pancreas

• Consider surgical intervention if the tumor is resectable.
• Chemotherapy may be indicated for advanced disease.
• Regular monitoring of blood glucose levels is essential.
• Provide nutritional counseling to address weight loss.

Using ICD-10 Code C25.4 for Malignant neoplasm of endocrine pancreas in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings.
• Use C25.4 in conjunction with relevant procedure codes for billing.
• Maintain detailed records of treatment plans and patient education.
• Review coding guidelines to ensure compliance with payer requirements.

Related ICD-10 Codes Often Used with Malignant neoplasm of endocrine pancreas

• C25.0 – Malignant neoplasm of pancreas, head
• C25.1 – Malignant neoplasm of pancreas, body
• C25.2 – Malignant neoplasm of pancreas, tail
• C25.3 – Malignant neoplasm of pancreas, unspecified

ICD-10 Code C25.4 in Medical Billing and Insurance for Malignant neoplasm of endocrine pancreas

ICD-10 Code C25.4 is critical for accurate billing in hospital, ER, or oncology settings.

Billing Notes:

• Document all relevant clinical findings to support the diagnosis.
• Use C25.4 in the primary diagnosis field for billing purposes.
• Ensure that treatment plans are clearly outlined in the medical record.
• Review payer-specific guidelines for coding and billing.

Common CPT Pairings: